Diadenosine pentaphosphate pentasodium

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Diadenosine pentaphosphate pentasodium

Diadenosine pentaphosphate pentasodium 是一种内源性血管活性嘌呤二核苷酸，可从血小板中分离出来。Diadenosine polyphosphates (ApnA, n=2–7) 已被确定为分泌小泡的成分，如血小板、嗜铬细胞、Torpedo 突出末端和脑突触体。

Diadenosine pentaphosphate pentasodium Chemical Structure

CAS No. : 4097-04-5

规格	价格	是否有货
1 mg	￥995	In-stock
5 mg	￥2980	In-stock
10 mg		询价
50 mg		询价

* Please select Quantity before adding items.

Diadenosine pentaphosphate pentasodium 相关产品

•相关化合物库:

Natural Product Library Plus
Bioactive Compound Library Plus
Metabolism/Protease Compound Library
Natural Product Library
Human Endogenous Metabolite Compound Library
Nucleotide Compound Library
Food-Sourced Compound Library
Human Metabolite Library
Coagulation and Anti-coagulation Compound Library
Animal-Sourced Natural Product Library

•同靶点产品:

•同靶点蛋白产品:

生物活性

Diadenosine pentaphosphate pentasodium is an endogenous vasoactive purine dinucleotide which has been isolated from thrombocytes. Diadenosine polyphosphates (ApnA, n=2–7) have been identified as constituents of secretory vesicles such as in platelets, chromaffin cells, Torpedo synaptic terminals and brain synaptosomes^[1]^[2].

IC₅₀ & Target

Human Endogenous Metabolite

分子量

1026.28

Formula

C₂₀H₂₄N₁₀Na₅O₂₂P₅

CAS 号

4097-04-5

性状

固体

颜色

White to off-white

结构分类

Others

初始来源

内源性代谢物

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

-20°C, sealed storage, away from moisture and light

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)

纯度 & 产品资料

纯度: ≥97.0%

选择批次：

Data Sheet (531 KB) SDS (252 KB)

COA (197 KB)

产品使用指南 (1538 KB)

参考文献

[1]. L Giraldez, et al. Adenosine triphosphate and diadenosine pentaphosphate induce [Ca(2+)](i) increase in rat basal ganglia aminergic terminals. J Neurosci Res. 2001 Apr 15;64(2):174-82. [Content Brief]

[2]. Jesús Pintor, et al. Presence of diadenosine polyphosphates in human tears. Pflugers Arch. 2002 Jan;443(3):432-6. [Content Brief]

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务